# Findvalue Asset Management

> Findvalue Asset Management is a VC fund in Yongdungpo backing Medical and Software. See 5 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Yongdungpo, South Korea
- Total investments: 5
- Last investment: Apr 2026
- Lead investor: 0%
- Last updated: Aug 2026
- Website: http://www.findvalue.co.kr/

Findvalue Asset Management is an investment and asset management company.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 2 | 40% |
| Software | 2 | 40% |
| Machine Learning | 2 | 40% |
| Artificial Intelligence | 2 | 40% |
| Chemical | 1 | 20% |

15 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 3 | 60% |
| Series A | 1 | 20% |
| Post-IPO Equity | 1 | 20% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| NEUROPHET | Neurophet is a medical technology enterprise that focuses on neuro-engineering and brain health. The company develops software programs that utilize artificial intelligence for the analysis of medical brain images. The firm creates simulation tools specifically for medical researchers and doctors who perform non-invasive electrical brainstimulation procedures. These applications allow medical professionals to generate three-dimensional models of individual human brains directly from magnetic resonance imaging data. | $10.8M | Post-IPO Equity | Apr 10, 2026 |  |
| VDream | VDream is a company that supports disabled people's social participation.VDream is the developer of a one-stop platform designed to offer recruitment opportunities to disabled people. | $6.2M | Series B | Feb 10, 2022 |  |
| Cell Lab Med | Cell Lab Med is a drug research and development company. | $19.7M | Series B | Nov 15, 2021 |  |
| AIDOT | AIDot developed Cerviray A.I., an artificial intelligence-based diagnostic solution that combines traditional cervical enlargement photography and artificial intelligence to make cervical cancer screening faster and more accurate -- in fact, we’ve achieved 90% accuracy in a certified test report in 2019. This is in contrast to the 50%false-negative rate common for cervical cancer tests. AIDOT's solution is handheld and uses a mobile phone or tablet. It enables any relevant healthcare professional to detect cervical dysplasia and cancer with just one click and around ten seconds of AI analysis, compared to around one week for traditional tests. | $2.6M | Series A | Aug 21, 2021 |  |
| PGT | PGT is a manufacturing company that develops specialty chemicals designed to be used as industrial raw materials. | $836.1K | Series B | Feb 01, 2020 |  |

5 of 5 investments shown.

## Co-investors
- [Korea Investment & Securities](https://shizune.co/investors/profile/korea-investment-securities-d0c5) — VC Fund, 2 deals together
- AION Capital Partners — VC Fund, 1 deal together
- Asset Management — VC Fund, 1 deal together
- [BA Partners](https://shizune.co/investors/profile/ba-partners) — VC Fund, 1 deal together
- FOCUS ASSET MANAGEMENT — VC Fund, 1 deal together
- [GVA Asset Management](https://shizune.co/investors/profile/gva-asset-management) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Findvalue Asset Management invest in?

Findvalue Asset Management invests primarily in Medical, Software and Machine Learning startups, most often at Series B and Series A stage. Most of the 5 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Findvalue Asset Management last invest?

The most recent investment recorded for Findvalue Asset Management closed in Apr 2026. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co